Since ER and PR immunostaining was increased after UPA use, the anti-angiogenic effect of UPA which results in amenorrhea, seems mostly based on the progesterone receptor antagonist effect and not merely on changes in VEGF. This evidence concerns the gene ESR1 and amenorrhea.